|
|
|
Insider
Information: |
Mario Ernest |
Relationship: |
Director |
City: |
Redwood City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
13 |
|
Direct
Shares |
1,151,697 |
|
Indirect Shares
|
265,510 |
|
|
Direct
Value |
$8,534,238 |
|
|
Indirect Value
|
$109,674 |
|
|
Total
Shares |
1,417,207 |
|
|
Total
Value |
$8,643,912 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-41.7%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Maxygen Inc |
MAXY |
Director |
2012-06-06 |
62,964 |
2003-08-05 |
0 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director |
2004-05-05 |
70,431 |
2004-05-05 |
85,554 |
Premium* |
|
Pharmaceutical Product Developme... |
PPDI |
Director |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
Boston Scientific Corp |
BSX |
Director |
2015-11-16 |
86,032 |
2013-11-08 |
0 |
Premium* |
|
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2006-03-08 |
18,181 |
|
0 |
Premium* |
|
Celgene Corp |
CELG |
|
2019-11-20 |
0 |
2019-11-20 |
0 |
Premium* |
|
Vivus Inc |
VVUS |
Director |
2013-05-29 |
81,125 |
2012-04-25 |
0 |
Premium* |
|
Xenoport Inc |
XNPT |
Director |
2015-05-19 |
88,750 |
2012-08-09 |
0 |
Premium* |
|
Tonix Pharmaceuticals Holding Corp |
TNXP |
Director |
2018-02-09 |
0 |
2018-06-25 |
50,000 |
Premium* |
|
Chimerix Inc |
CMRX |
Director |
2018-05-18 |
12,905 |
2018-05-18 |
108,167 |
Premium* |
|
Kindred Biosciences, Inc. |
KIN |
Director |
2018-10-29 |
169,000 |
2013-12-12 |
0 |
Premium* |
|
Soleno Therapeutics Inc |
SLNO |
|
2024-05-21 |
186,566 |
2024-05-21 |
21,789 |
Premium* |
|
Eyenovia Inc |
EYEN |
Director |
2021-01-15 |
375,743 |
2018-07-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
373 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 12 of 15
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BSX |
Boston Scientific Corp |
Director |
|
2014-05-01 |
4 |
AS |
$12.58 |
$125,836 |
D/D |
(10,000) |
317,855 |
0 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2014-09-02 |
4 |
AS |
$12.60 |
$125,992 |
D/D |
(10,000) |
277,855 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2011-11-02 |
4 |
A |
$63.00 |
$126,000 |
D/D |
2,000 |
44,370 |
0 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2014-12-18 |
4 |
OE |
$4.25 |
$127,500 |
D/D |
30,000 |
166,472 |
0 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2014-06-02 |
4 |
AS |
$12.88 |
$128,790 |
D/D |
(10,000) |
307,855 |
0 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2014-07-01 |
4 |
AS |
$12.95 |
$129,468 |
D/D |
(10,000) |
297,855 |
0 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2014-12-01 |
4 |
AS |
$12.96 |
$129,618 |
D/D |
(10,000) |
261,032 |
0 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2014-03-03 |
4 |
AS |
$12.98 |
$129,755 |
D/D |
(10,000) |
337,855 |
0 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2014-02-03 |
4 |
AS |
$13.19 |
$131,884 |
D/D |
(10,000) |
364,959 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2010-06-03 |
4 |
B |
$53.00 |
$132,500 |
D/D |
2,500 |
22,500 |
2.39 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2011-11-21 |
4 |
B |
$5.30 |
$132,500 |
D/D |
25,000 |
306,004 |
2.39 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2014-11-03 |
4 |
AS |
$13.30 |
$132,998 |
D/D |
(10,000) |
271,032 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2011-03-15 |
4 |
B |
$53.33 |
$133,320 |
D/D |
2,500 |
36,685 |
2.39 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2014-04-01 |
4 |
AS |
$13.55 |
$135,527 |
D/D |
(10,000) |
327,855 |
0 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2011-10-25 |
4 |
B |
$5.50 |
$137,500 |
D/D |
25,000 |
256,004 |
2.39 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2018-05-11 |
4 |
S |
$4.57 |
$138,380 |
I/I |
(30,000) |
235,720 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2014-07-24 |
4 |
OE |
$27.69 |
$138,450 |
D/D |
5,000 |
229,358 |
0 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2018-05-15 |
4 |
S |
$4.69 |
$140,808 |
I/I |
(30,000) |
183,167 |
0 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2014-05-27 |
4 |
B |
$14.22 |
$142,200 |
D/D |
10,000 |
68,451 |
2.39 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2018-05-16 |
4 |
S |
$4.79 |
$143,808 |
I/I |
(30,000) |
153,167 |
0 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2018-05-17 |
4 |
S |
$4.80 |
$143,931 |
I/I |
(30,000) |
123,167 |
0 |
- |
|
KIN |
Kindred Biosciences, Inc. |
Director |
|
2018-10-29 |
4 |
OE |
$1.37 |
$152,941 |
D/D |
44,833 |
169,000 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2016-04-26 |
4 |
OE |
$31.80 |
$158,975 |
D/D |
5,000 |
101,924 |
0 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2012-08-06 |
4 |
B |
$5.29 |
$169,280 |
D/D |
32,000 |
479,304 |
2.39 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2016-03-16 |
4 |
B |
$2.29 |
$171,713 |
D/D |
75,000 |
341,472 |
2.39 |
- |
|
373 Records found
|
|
Page 12 of 15 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|